Monday, June 15, 2026

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Investors Punish Apple: Shares Slide After Underwhelming iPhone Reveal

Apple's stock fell 3.23% due to disappointment with the new iPhone Air and other product launches, leading to investor skepticism.

Tag: Remix

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.